Italia markets open in 3 hours 4 minutes

TEVA Aug 2024 18.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,3100-0,0200 (-6,06%)
In data: 03:57PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,3300
Aperto0,3100
Denaro0,2700
Domanda0,3400
Prezzo d'esercizio18,00
Scadenza2024-08-02
Min-Max giorno0,3100 - 0,3100
Contratto - Min-MaxN/D
Volume1
Open Interest190
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.